WTO's COVID deal: more vaccine ‘enabler’ than IP waiver?

After several days and sleepless nights, members of the World Trade Organisation (WTO) finally agreed several key trade initiatives last week, including one that promises to suspend patent protection of the COVID-19 vaccines.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

Pfizer’s US Paxlovid patent fight turns on a single error

25 June 2026 The Federal Circuit has brought Paxloid’s infringement case to an end, serving as a reminder that even minor changes to patent language can have major consequences.

Biotechnology

Novartis and Eli Lilly sign separate $1.9bn novel drug deals

25 June 2026 Novartis will work with a US biotech company on new cancer therapies, while Lilly has partnered with a Chinese biopharma firm to develop new medicines.

Europe

Novo secures website blocking to tackle fake weight-loss drugs

25 June 2026 A UK judge extends a blocking order aimed at ISPs including BT, EE, and Sky, allowing the maker of Ozempic and Wegovy to add infringing sites that sell counterfeits without returning to court.

More features

Pfizer’s US Paxlovid patent fight turns on a single error

GLP-1 patents and Africa: The COVID-19 lessons we still have not learned

Moderna: BioNTech is claiming work ‘it never did’

Heated LNP litigation puts Moderna and Acuitas in the spotlight

Moderna loses key mRNA patent in European vaccine fight

CureVac targets Moderna with 10-patent suit over Spikevax

Patent office fee increases: What applicants must know

IndiaMart v CDSCO: A test of intermediary liability

WTO's COVID deal: more vaccine ‘enabler’ than IP waiver?

More on this story

Editor's picks

Editor's picks

More features